| News | April 2021 | Cases&Lacambra has advised the Seller on the sale of Cocoon Medical to Sinclair Pharma |

This M&A transaction consisted in a 100% sale of all the Cocoon Medical group companies (i.e., the entities of Cocoon Medical in Spain, USA, Hong Kong, Italy, Bulgaria and Colombia) to Sinclair Pharma, which belongs to the listed Chinese entity Huadong Medicine Co., Ltd. (which is listed in the Shenzhen Stock Exchange Market).

The signing of the transaction took place in February 2021 and it was closed on 12 April 2021. The transaction has been successfully negotiated and closed within an extremely scenario due to COVID-19 restrictions.

This multijurisdictional deal involved the participation of legal counsels from Spain, USA, Hong Kong, Italy, Bulgaria and Colombia. Cases&Lacambra acted as leading legal counsel of the Seller. The team was led by partner Bojan Radovanovic and involved various associated, including Marc Roig.